Skip to main content
Fig. 1 | Neurological Research and Practice

Fig. 1

From: Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis

Fig. 1

cMRI imaging of a 63 years old patient at a initial diagnosis (T1 weighted imaging with contrast medium), b at relapse (T1 weighted imaging with contrast medium), c also at relapse (diffusion weighted imaging) and d at remission after HD-MTX based retreatment plus focal radiotherapy (T1 weighted imaging with contrast medium)

Back to article page